Title: Mycophenolate Mofetil Versus Azathioprine as a First-Line Treatment for Autoimmune
Hepatitis: A Comparative Systematic Review and Meta-Analysis
Version: 5 Date: 10 Jul 2025
Reviewer:  Avinash Tiwari
Reviewer's report:
Dear Authors,
Thank you for the thoughtful revision of the manuscript titled "Mycophenolate Mofetil Versus
Azathioprine as a First-Line Treatment for Autoimmune Hepatitis: A Comparative Systematic
Review and Meta-Analysis." The authors have adequately addressed the initial concerns, and the
updated version presents a clearer methodological approach and strengthened conclusions. The
comparative analysis is well supported and contributes meaningfully to the evolving discourse
on first-line treatment options in autoimmune hepatitis.
I am satisfied with the revisions and have no further major concerns. I commend the authors for
their responsiveness to reviewer feedback and their commitment to improving the manuscript’s
rigor and clarity.
Title: Mycophenolate Mofetil Versus Azathioprine as a First-Line Treatment for Autoimmune
Hepatitis: A Comparative Systematic Review and Meta-Analysis
Version: 5 Date: 10 Jul 2025
Reviewer:  Avinash Tiwari
Reviewer's report:
Dear Authors,
Thank you for the thoughtful revision of the manuscript titled "Mycophenolate Mofetil Versus
Azathioprine as a First-Line Treatment for Autoimmune Hepatitis: A Comparative Systematic
Review and Meta-Analysis." The authors have adequately addressed the initial concerns, and the
updated version presents a clearer methodological approach and strengthened conclusions. The
comparative analysis is well supported and contributes meaningfully to the evolving discourse
on first-line treatment options in autoimmune hepatitis.
I am satisfied with the revisions and have no further major concerns. I commend the authors for
their responsiveness to reviewer feedback and their commitment to improving the manuscript’s
rigor and clarity.
Please review this paper.
user
Title: Mycophenolate Mofetil Versus Azathioprine as a First-Line Treatment for Autoimmune
Hepatitis: A Comparative Systematic Review and Meta-Analysis
Version: 5 Date: 10 Jul 2025
Reviewer:  Avinash Tiwari
Reviewer's report:
Dear Authors,
Thank you for the thoughtful revision of the manuscript titled "Mycophenolate Mofetil Versus
Azathioprine as a First-Line Treatment for Autoimmune Hepatitis: A Comparative Systematic
Review and Meta-Analysis." The authors have adequately addressed the initial concerns, and the
updated version presents a clearer methodological approach and strengthened conclusions. The
comparative analysis is well supported and contributes meaningfully to the evolving discourse
on first-line treatment options in autoimmune hepatitis.
I am satisfied with the revisions and have no further major concerns. I commend the authors for
their responsiveness to reviewer feedback and their commitment to improving the manuscript’s
rigor and clarity.
assistant